Cargando…

Topical tacrolimus for refractory superficial mucoceles in a patient with chronic graft versus host disease

Detalles Bibliográficos
Autores principales:	Deutsch, Alana, McLellan, Beth N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7200197/ https://www.ncbi.nlm.nih.gov/pubmed/32382636 http://dx.doi.org/10.1016/j.jdcr.2020.02.041

Ejemplares similares

Palatal superficial mucoceles associated with chronic graft-versus-host disease
por: Masri, Bilal Al, et al.
Publicado: (2023)

Severe onycholysis and eyelash trichomegaly in a patient treated with erdafitinib
por: Deutsch, Alana, et al.
Publicado: (2020)

Single-cell transcriptomics in dermatology
por: Deutsch, Alana, et al.
Publicado: (2020)

Superficial Mucocele: A Rare Presentation
por: Venugopal, Divyambika C, et al.
Publicado: (2021)

Tacrolimus/methotrexate vs tacrolimus/reduced-dose methotrexate/mycophenolate for graft-versus-host disease prevention
por: Hamilton, Betty K., et al.
Publicado: (2023)

Incidental improvement of programmed cell death-1 receptor inhibitor-induced vitiligo after initiation of dupilumab therapy for refractory pruritus
por: Robinson, Warner, et al.
Publicado: (2023)

An Unusual Presentation of Multiple Superficial Mucoceles Occurring with Oral Lichen Planus
por: Rungraungrayabkul, Dulyapong, et al.
Publicado: (2021)

Therapy with mycophenolate mofetil for refractory acute and chronic graft-versus-host disease
por: Furlong, Terry, et al.
Publicado: (2009)

Estrogen-deficient skin: The role of topical therapy()()
por: Rzepecki, Alexandra K., et al.
Publicado: (2019)

Oral mucositis after tacrolimus/sirolimus or cyclosporine/methotrexate as graft‐versus‐host disease prophylaxis
por: Garming Legert, Karin, et al.
Publicado: (2020)

Late Onset and Protracted Course of Steroid Refractory Chronic Graft-versus-Host Disease
por: Gunes, Gursel, et al.
Publicado: (2015)

Combination of bortezomib plus ruxolitinib in steroid-refractory chronic graft-versus-host disease
por: Kaloyannidis, Panayotis, et al.
Publicado: (2018)

Steroid-refractory chronic graft-versus-host disease: treatment options and patient management
por: Wolff, Daniel, et al.
Publicado: (2021)

Efficacy and Safety of Topical Corticosteroids for Management of Oral Chronic Graft versus Host Disease
por: Elsaadany, Basma Abdelaleem, et al.
Publicado: (2017)

Superficial mucoceles in cancer patients: a retrospective series from a Stomatology unit
por: Heguedusch, Daniele, et al.
Publicado: (2023)

Successful Treatment of Refractory Ulcerative Proctitis in a Pediatric Patient Using Topical Tacrolimus
por: Nowacki, Rélana, et al.
Publicado: (2020)

Murine Models of Steroid Refractory Graft-versus-Host Disease
por: Toubai, Tomomi, et al.
Publicado: (2018)

Topical Spironolactone in the Treatment of Ocular Graft-Versus-Host Disease
por: Wong, Calvin W, et al.
Publicado: (2023)

Therapeutic Effect of 0.03% Tacrolimus Ointment for Ocular Graft versus Host Disease and Vernal Keratoconjunctivitis
por: Ryu, Eun Hye, et al.
Publicado: (2012)

Ruxolitinib in refractory acute and chronic graft-versus-host disease: a multicenter survey study
por: Escamilla Gómez, Virginia, et al.
Publicado: (2019)

Refractory Epidermolysis Bullosa Acquisita with Chronic Graft-versus-Host Disease Successfully Treated with Rituximab
por: Han, Ju Hee, et al.
Publicado: (2023)

Aqueous penetration of topical tacrolimus
por: Shoughy, Samir S., et al.
Publicado: (2020)

COVID toes: Phenomenon or epiphenomenon?
por: Deutsch, Alana, et al.
Publicado: (2020)

Incidence of Topical Tacrolimus Adverse Effects in Chronic Skin Disease
por: Park, Hyung-jin, et al.
Publicado: (2019)

Mucocele
por: Castillo Velasco, María Soraya
Publicado: (2004)

Mucocele
Publicado: (1892)

Experimental Pharmaceuticals for Steroid-Refractory Acute Graft-versus-Host Disease
por: Abedin, Sameem, et al.
Publicado: (2020)

Efficiency and Toxicity of Ruxolitinib as a Salvage Treatment for Steroid-Refractory Chronic Graft-Versus-Host Disease
por: Wang, Dong, et al.
Publicado: (2021)

Extracorporeal photopheresis in acute and chronic steroid‑refractory graft-versus-host disease: an evolving treatment landscape
por: Greinix, Hildegard T., et al.
Publicado: (2022)

Treatment of refractory juvenile dermatomyositis with tacrolimus
por: Hassan, J, et al.
Publicado: (2008)

Radiation-related superficial oral mucoceles: An under-recognized acute toxicity in head and neck cancer patients
por: Prado-Ribeiro, Ana-Carolina, et al.
Publicado: (2018)

Therapeutic effects of topical 0.03% Tacrolimus ointment in children with refractory vernal keratoconjunctivitis in Middle East
por: Fiorentini, Sandra Flavia, et al.
Publicado: (2019)

Tocilizumab, tacrolimus and methotrexate for the prevention of acute graft-versus-host disease: low incidence of lower gastrointestinal tract disease
por: Drobyski, William R., et al.
Publicado: (2018)

Topical tacrolimus as treatment of atopic dermatitis
por: Furue, Masutaka, et al.
Publicado: (2009)

Treatment of nodular scabies with topical tacrolimus
por: Mittal, Asit, et al.
Publicado: (2013)

Topical tacrolimus for the treatment of secondary lymphedema
por: Gardenier, Jason C., et al.
Publicado: (2017)

Zoon's balanitis treated with topical tacrolimus
por: Daga, Sudarshan O., et al.
Publicado: (2017)

Dermoscopy of oral mucocele: three types of extravasation mucoceles
por: AYHAN, Erhan, et al.
Publicado: (2020)

Intramesenteric Steroid Treatment for Steroid- Refractory Gastrointestinal Graft Versus Host Disease
por: Bilgin, Aynur Uğur, et al.
Publicado: (2012)

Treatment and unmet needs in steroid-refractory acute graft-versus-host disease
por: Malard, Florent, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_q23303lfu74ruc1fm4ctt9nigu